Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionEP Wealth Advisors, Inc.
Latest Disclosed Ownership37,111 shares
Latest Disclosed Value $ 5,668,686
EP Wealth Advisors, Inc. reports 118.60% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 14, 2026 - EP Wealth Advisors, Inc. filed a 13F-HR form disclosing ownership of 37,111 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $5,668,705 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 16,977 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 118.60% during the quarter. The current value of the position is $5,535,477 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 37,111 20,134 118.60 5,669 142.22 0.0278
2026-02-18 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 16,977 4,427 35.27 2,341 54.15 0.0122
2025-08-14 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 12,550 1,191 10.49 1,519 19.91 0.0100
2025-05-15 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 11,359 -641 -5.34 1,266 8.48 0.0101
2025-02-14 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 12,000 -1,630 -11.96 1,168 -25.53 0.0095
2024-11-15 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 13,630 1,837 15.58 1,568 24.86 0.0135
2024-08-19 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 11,793 -1,311 -10.00 1,256 -0.95 0.0133
2024-05-14 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 13,104 2,052 18.57 1,268 13.63 0.0148
2024-02-28 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 11,052 -1,196 -9.76 1,116 -10.59 0.0142
2023-11-24 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 12,248 -16,000 -56.64 1,248 57.05 0.0194
2023-08-14 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 28,248 8,988 46.67 795 -74.09 0.0115
2023-06-05 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 19,260 14,185 279.51 3,065 566.30 0.0527
2023-06-12 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 5,075 5,075 460 0.0083
2022-12-02 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 0 -10,800 -100.00 0 -100.00
2022-08-11 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 10,800 2,631 32.21 913 27.34 0.0206
2022-05-20 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 8,169 -315 -3.71 717 -3.37 0.0157
2022-02-17 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,484 406 5.03 742 12.25 0.0175
2021-11-23 2021-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 8,078 790 10.84 661 -0.60 0.0181
2021-11-16 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,224 -4,064 661 0.0181
2021-08-24 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,288 826 12.78 665 20.47 0.0184
2021-05-17 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,462 34 0.53 552 -9.06 0.0175
2021-02-18 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,428 -1,043 -13.96 607 -6.62 0.0213
2020-11-17 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,471 921 14.06 650 13.64 0.0280
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,550 -1,399 -17.60 572 -12.67 0.0244
2020-05-18 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 7,949 202 2.61 655 -10.76 0.0321
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 7,747 -191 -2.41 734 6.38 0.0302
2019-11-18 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 7,938 1,912 31.73 690 25.45 0.0342
2019-08-27 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 6,026 3,588 147.17 550 135.04 0.0344
2019-05-20 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,438 23 0.95 234 13.04 0.0225
2019-02-15 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,415 2,415 207 0.0160
2016-08-15 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -130,738 -100.00 0 -100.00
2016-05-16 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 130,738 -8,147 -5.87 9,471 -20.74 1.4524
2016-02-16 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 138,885 1,483 1.08 11,950 -5.38 2.0087
2015-11-17 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 137,402 -626 -0.45 12,630 -6.95 2.4075
2015-08-14 2015-06-30 13F Novartis AG ADS Common 66987V109 138,028 2,499 1.84 13,574 1.56 2.5438
2015-05-15 2015-03-31 13F Novartis AG ADS Common 66987V109 135,529 -1,320 -0.96 13,364 5.39 2.5131
2015-02-17 2014-12-31 13F Novartis AG ADS Common 66987V109 136,849 -53 -0.04 12,680 -1.61 2.0896
2014-11-12 2014-09-30 13F Novartis AG ADS Common 66987V109 136,902 5,354 4.07 12,887 8.21 2.0870
2014-07-25 2014-06-30 13F Novartis AG ADS Common 66987V109 131,548 2,862 2.22 11,909 8.85 2.7675
2014-05-15 2014-03-31 13F NovartisAGADS Common 66987V109 128,686 2,729 2.17 10,941 8.07 2.9924
2014-02-14 2013-12-31 13F Novartis AG ADS Common 66987V109 125,957 3,678 3.01 10,124 7.93 2.6257
2013-11-14 2013-09-30 13F Novartis AG ADS Common 66987V109 122,279 4,954 4.22 9,380 13.07 2.9472
2013-08-14 2013-06-30 13F Novartis AG ADS Common 66987V109 117,325 117,325 8,296 2.9932
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.